Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA delays review of BioMarin's Vimizim by three months
FDA delays review of BioMarin's Vimizim by three months
FDA delays review of BioMarin's Vimizim by three months
Submitted by
admin
on May 30, 2013 - 11:33am
Source:
The Fly on the Wall
News Tags:
Vimizim
FDA
Biomarin
Headline:
FDA delays review of BioMarin's Vimizim by three months
Do Not Allow Advertisers to Use My Personal information
